DNA Panels Could Predict Endoscopic Response to Biologics in CD DNA Panels Could Predict Endoscopic Response to Biologics in CD
Peripheral blood biomarkers in development that use DNA methylation could predict endoscopic response to treatment with adalimumab, vedolizumab, and ustekinumab for patients with Crohn ' s disease.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
More News: Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Humira | Inflammatory Bowel Disease | Stelara